POC PT INR - coagucheck
Ended Awarded Last action
- Contract number
- 36C24220A0009
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Veterans Integrated Service Network 2
Veterans Health Administration, Department of Veterans Affairs
- Task orders
- 5 $50,899 obligated
Award facts
- Opportunity
-
- 6640--POC PT INR - SOUTH (Bronx, NY Harbor {Manhattan, Brooklyn} Test Volumes change from 17, 801 to 11, 110 Solicitation · 36C24219Q0824 · Posted Dec 23, 2019
- Combined order value
- $50,899 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling 17% used
- $305,532.40
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 awarded a blanket purchase agreement to Roche Diagnostics Corporation for point-of-care prothrombin time international normalized ratio coagulation testing devices and related supplies. The original solicitation sought proposals to provide portable analyzers and consumables for waived and non-waived PT/INR testing at VA medical centers in Bronx, Brooklyn, and Manhattan to support care for veterans within the network.
Over the five-year period of performance from March 2020 to February 2025, Roche Diagnostics Corporation has received multiple firm fixed price calls against its General Services Administration Federal Supply Schedule contract for In Vitro Diagnostics, Reagents, and Tests. Deliveries have been made to locations in Bronx, New York and Castleton, Indiana, with potential contract values ranging from zero to $305,532.40 to supply ongoing medical testing requirements. No set-aside provisions were applied. The blanket purchase agreement and associated task orders aim to ensure veterans integrated within the network continue receiving reliable blood coagulation monitoring through use of the contractor's point-of-care testing platform.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $0 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $0 | |
| Exercise an Option | $0 | |
| Change Order | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36C24220A0009?
36C24220A0009 was awarded to Roche Diagnostics Corporation by Veterans Integrated Service Network 2 (Veterans Health Administration) on March 1, 2020.
How much is contract 36C24220A0009 worth?
Orders under 36C24220A0009 have obligated $50,899. 36C24220A0009's own ceiling is $305,532.
How many orders have been placed under contract 36C24220A0009?
5 orders have been placed under 36C24220A0009, the latest on March 1, 2024.
Who can order from contract 36C24220A0009?
36C24220A0009 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36C24220A0009 under another contract?
Yes. 36C24220A0009 is a blanket purchase agreement under V797P5279B, a federal supply schedule, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract 36C24220A0009 competed?
The extent of competition for 36C24220A0009 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV